Active	Status	Sponsor type	Region	Phase	Filter
7 Active 6 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Adagio (insulin) / Aerami Therap, Hikma
NCT07011732: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Not yet recruiting	3	352	Europe, Canada, Japan, US, RoW	Xanomeline/Trospium Chloride Capsule, KarXT, BMS-986510, Xanomeline Enteric Capsule, KarX-EC, BMS-986519, Placebo	Bristol-Myers Squibb	Alzheimer Disease	11/28	12/28
NCT07011745: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)	Not yet recruiting	3	352	Europe, US, RoW	Xanomeline/Trospium Chloride Capsule, KarXT, BMS-986510, Xanomeline Enteric Capsule, KarX-EC, BMS-986519, Placebo	Bristol-Myers Squibb	Alzheimer Disease	10/28	11/28
ADAGIO-3, NCT06937229: A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease	Not yet recruiting	3	600	Europe, Japan, US, RoW	KarXT, Xanomeline and Trospium Chloride capsule, BMS-986510, KarX-EC, Xanomeline enteric capsules, BMS-986519	Bristol-Myers Squibb	Alzheimer Disease, Agitation	06/29	07/29
2015-003737-95: A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)	Ongoing	2	12	Europe	Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog	Dance Biopharm Inc., Dance Biopharm Inc.	Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
2015-003672-76: A Study to Investigate the Dose Response of Dance 501 in Subjects with Type 1 Diabetes Mellitus (T1DM)	Ongoing	2	24	Europe	Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog	Dance Biopharm Inc., Dance Biopharm Inc.	Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
ADAGiO, NCT06254326: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients	Recruiting	1	12	US	TTRNA-DC vaccines with GM-CSF, Autologous Hematopoietic Stem cells (HSCs), TTRNA-xALT, Td vaccine	University of Florida, Oligo Nation, Inc	Recurrent Oligodendroglioma, Progressive Oligodendroglioma	12/27	06/28
NCT06384599: VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study	Not yet recruiting	N/A	130	Europe	VT Cryoablation System	Adagio Medical	Ventricular Tachycardia	06/26	06/26
imatinib (AER-901) / Aerami Therap
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Adagio (insulin) / Aerami Therap, Hikma
NCT07011732: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)	Not yet recruiting	3	352	Europe, Canada, Japan, US, RoW	Xanomeline/Trospium Chloride Capsule, KarXT, BMS-986510, Xanomeline Enteric Capsule, KarX-EC, BMS-986519, Placebo	Bristol-Myers Squibb	Alzheimer Disease	11/28	12/28
NCT07011745: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)	Not yet recruiting	3	352	Europe, US, RoW	Xanomeline/Trospium Chloride Capsule, KarXT, BMS-986510, Xanomeline Enteric Capsule, KarX-EC, BMS-986519, Placebo	Bristol-Myers Squibb	Alzheimer Disease	10/28	11/28
ADAGIO-3, NCT06937229: A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease	Not yet recruiting	3	600	Europe, Japan, US, RoW	KarXT, Xanomeline and Trospium Chloride capsule, BMS-986510, KarX-EC, Xanomeline enteric capsules, BMS-986519	Bristol-Myers Squibb	Alzheimer Disease, Agitation	06/29	07/29
2015-003737-95: A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)	Ongoing	2	12	Europe	Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog	Dance Biopharm Inc., Dance Biopharm Inc.	Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
2015-003672-76: A Study to Investigate the Dose Response of Dance 501 in Subjects with Type 1 Diabetes Mellitus (T1DM)	Ongoing	2	24	Europe	Dance 501 Human Insulin Inhalation Solution, Nebuliser solution, Solution for injection, Humalog	Dance Biopharm Inc., Dance Biopharm Inc.	Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus, Diseases [C] - Nutritional and Metabolic Diseases [C18]
ADAGiO, NCT06254326: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients	Recruiting	1	12	US	TTRNA-DC vaccines with GM-CSF, Autologous Hematopoietic Stem cells (HSCs), TTRNA-xALT, Td vaccine	University of Florida, Oligo Nation, Inc	Recurrent Oligodendroglioma, Progressive Oligodendroglioma	12/27	06/28
NCT06384599: VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study	Not yet recruiting	N/A	130	Europe	VT Cryoablation System	Adagio Medical	Ventricular Tachycardia	06/26	06/26
imatinib (AER-901) / Aerami Therap
No trials found